These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11389575)

  • 1. Bronchodilatory effects of salbutamol, ipratropium bromide, and their combination: double-blind, placebo-controlled crossover study in cystic fibrosis.
    Ziebach R; Pietsch-Breitfeld B; Bichler M; Busch A; Riethmüller J; Stern M
    Pediatr Pulmonol; 2001 Jun; 31(6):431-5. PubMed ID: 11389575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of high doses of inhaled salbutamol and ipratropium bromide in patients with stable cystic fibrosis.
    Sanchez I; De Koster J; Holbrow J; Chernick V
    Chest; 1993 Sep; 104(3):842-6. PubMed ID: 8365299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
    Balkissoon R; Make B
    COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD.
    Singh D; Abbott-Banner K; Bengtsson T; Newman K
    Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30166326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of higher than standard doses of salbutamol and ipratropium on tiotropium-induced bronchodilation in patients with stable COPD.
    Cazzola M; Santus P; D'Adda A; Pizzolato S; Di Marco F; Centanni S
    Pulm Pharmacol Ther; 2009 Jun; 22(3):177-82. PubMed ID: 19038356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of acute bronchodilator effects of inhaled ipratropium bromide and salbutamol in bronchial asthma.
    Chhabra SK; Pandey KK
    J Asthma; 2002 Aug; 39(5):375-81. PubMed ID: 12214891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD.
    Oga T; Nishimura K; Tsukino M; Sato S; Hajiro T; Mishima M
    Chest; 2003 Jun; 123(6):1810-6. PubMed ID: 12796154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchodilation and safety of supratherapeutic doses of salbutamol or ipratropium bromide added to single dose GSK961081 in patients with moderate to severe COPD.
    Norris V; Ambery C
    Pulm Pharmacol Ther; 2013 Oct; 26(5):574-80. PubMed ID: 23524017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials.
    Lanes SF; Garrett JE; Wentworth CE; Fitzgerald JM; Karpel JP
    Chest; 1998 Aug; 114(2):365-72. PubMed ID: 9726716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study.
    D'Urzo AD; De Salvo MC; Ramirez-Rivera A; Almeida J; Sichletidis L; Rapatz G; Kottakis J;
    Chest; 2001 May; 119(5):1347-56. PubMed ID: 11348938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B; Markham A
    Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of salbutamol and ipratropium bromide in decreasing bronchial hyperreactivity in children with cystic fibrosis.
    Avital A; Sanchez I; Chernick V
    Pediatr Pulmonol; 1992 May; 13(1):34-7. PubMed ID: 1534166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of inhaled albuterol and ipratropium bromide on autonomic control of the cardiovascular system.
    Dagnone AJ; Parlow JL
    Chest; 1997 Jun; 111(6):1514-8. PubMed ID: 9187166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, placebo-controlled, double-blind trial on the management of post-infective cough by inhaled ipratropium and salbutamol administered in combination.
    Zanasi A; Lecchi M; Del Forno M; Fabbri E; Mastroroberto M; Mazzolini M; Pisani L; Pandolfi P; Nava S; Morselli-Labate AM
    Pulm Pharmacol Ther; 2014 Dec; 29(2):224-32. PubMed ID: 25111667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial.
    Donohue JF; Wise R; Busse WW; Garfinkel S; Zubek VB; Ghafouri M; Manuel RC; Schlenker-Herceg R; Bleecker ER
    BMC Pulm Med; 2016 Apr; 16(1):65. PubMed ID: 27130202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department.
    Rodrigo GJ; Rodrigo C
    Am J Respir Crit Care Med; 2000 Jun; 161(6):1862-8. PubMed ID: 10852758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD.
    Bhattacharya A; Bhargava S; Singh V; Talwar D; Whig J; Rebello J; Purandare S; Gogtay J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1469-76. PubMed ID: 27418820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind, placebo-controlled trial of intravenous salbutamol and nebulized ipratropium bromide in early management of severe acute asthma in children presenting to an emergency department.
    Browne GJ; Trieu L; Van Asperen P
    Crit Care Med; 2002 Feb; 30(2):448-53. PubMed ID: 11889328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily variation in lung function in COPD patients with combined albuterol and ipratropium: results from a 4-week, randomized, crossover study.
    Singh D; Zhu CQ; Sharma S; Church A; Kalberg CJ
    Pulm Pharmacol Ther; 2015 Apr; 31():85-91. PubMed ID: 25197005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhalation by nebulization of albuterol-ipratropium combination (Dey combination) is superior to either agent alone in the treatment of chronic obstructive pulmonary disease. Dey Combination Solution Study Group.
    Gross N; Tashkin D; Miller R; Oren J; Coleman W; Linberg S
    Respiration; 1998; 65(5):354-62. PubMed ID: 9782217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.